Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-21-000450
Filing Date
2021-08-19
Accepted
2021-08-19 12:00:30
Documents
40
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 abti10q.htm   iXBRL 10-Q 268225
2 GRAPHIC image_001.gif GRAPHIC 5157
8 ex4_1.htm EX-4.1 117921
9 ex10_1.htm EX-10.1 206832
10 ex10_2.htm EX-10.2 73207
11 ex31_1.htm EX-31.1 9001
12 ex31_2.htm EX-31.2 9008
13 ex32_1.htm EX-32.1 5014
  Complete submission text file 0001663577-21-000450.txt   2057747

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abti-20210630.xsd EX-101.SCH 13761
4 XBRL CALCULATION FILE abti-20210630_cal.xml EX-101.CAL 20023
5 XBRL DEFINITION FILE abti-20210630_def.xml EX-101.DEF 24354
6 XBRL LABEL FILE abti-20210630_lab.xml EX-101.LAB 119532
7 XBRL PRESENTATION FILE abti-20210630_pre.xml EX-101.PRE 95264
14 EXTRACTED XBRL INSTANCE DOCUMENT abti10q_htm.xml XML 125904
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-156091 | Film No.: 211189279
SIC: 1000 Metal Mining